ArticleExperimental and therapeutic medicine2018

The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.

Ali Parlar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.